Business Wire

MO-BENSON-HILL

18.1.2023 13:01:35 CET | Business Wire | Press release

Share
Benson Hill Achieves ProTerra Sustainability Certification for its Proprietary Non-GMO Soy Portfolio

Benson Hill, Inc. (NYSE: BHIL, the “Company” or “Benson Hill”), a food tech company unlocking the natural genetic diversity of plants, announced today that it became one of the first U.S.-based ingredient providers to achieve the international ProTerra Certification, a rigorous global standard that sets the bar for sustainable agricultural practices and labor practices as well as segregated non-GMO programs and more. Benson Hill also joins the respected ProTerra Network, a group of companies dedicated to sustainable practices and continuous improvement.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230118005254/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Benson Hill Achieves ProTerra Sustainability Certification for its Proprietary Non-GMO Soy Portfolio. The company is one of the first U.S.-based ingredient providers to verify its sustainable practices under rigorous global standard. (Photo: Business Wire)

The ProTerra Certification program promotes social and environmental sustainability through food and feed supply chains, to support efforts to continuously improve day-to-day business operations and to help organizations to engage and implement the concept of sustainable development.

Throughout an extensive certification process, Benson Hill completed audits of its Creston, Iowa, and Seymour, Ind., plants as well as two shipping ports that store and transport its non-GMO soymeal. Benson Hill also partnered with its growers to conduct several on-farm visits. These in-depth audits examined data related to identity preservation along with deforestation practices, biodiversity efforts, and other Environmental, Social and Governance (ESG) metrics such as fair labor practices.

“I am delighted to welcome Benson Hill as a ProTerra Network Member. This certification demonstrates their engagement to continuously improve agricultural practices and achieve full transparency in the food supply chain,” said Emese van Maanen, Managing Director for the ProTerra Foundation. “Collaboration with farmers is essential to developing long-term relationships that create benefits from plant to plate.”

“Through our journey with ProTerra we gained important insights to solidify our position as a global ingredients company focused on responsible growth,” said Andres Martin, Executive Vice President and General Manager, International for Benson Hill. “Achieving the ProTerra certification standard is a testament to the ESG principles guiding our work to sustainably deliver our non-GMO soybean portfolio to markets within and outside the United States.”

The ProTerra standard, against which organizations are certified, is based on the Basel Criteria for Responsible Soy (created by Coop Switzerland and World Wildlife Fund). Today the standard is applicable to all sectors of the food and agricultural system worldwide and at all stages of the food chain. In addition, ProTerra certification ensures that high quality supplies of crops, food, and feed, that are independently certified as non-GMO and produced with improved sustainability, are available on the global market. Benson Hill’s proprietary soy ingredient portfolio, designed to meet specific end uses with less processing and increased traceability, is currently available in North America and in Europe.

Benson Hill built its closed-loop business model on sustainable design and systems thinking, which means its products deliver benefits across the entire value chain, from seed to plate. For example, CleanCRUSH™ ingredients derived from the company’s proprietary soybean genetics are designed as a less-processed alternative to commodity soy protein concentrate (SPC). CleanCRUSH ingredients can also reduce the need for costly energy- and water-intensive protein concentrating steps traditionally required for plant-based protein and aquaculture feed applications. In SPC comparisons, this can result in up to a 50 to 90 percent reduction in CO2e, depending on the ingredient source, and up to a 70 percent reduction in water usage.

For more information about Benson Hill’s progress in assessing impact and setting the pace of innovation in food, download its inaugural Environmental, Social and Governance (ESG) Report released in July 2022.

About Benson Hill

Benson Hill moves food forward with the CropOS® platform, a cutting-edge food innovation engine that combines data science and machine learning with biology and genetics. Benson Hill empowers innovators to unlock nature’s genetic diversity from plant to plate, with the purpose of creating nutritious, great-tasting food and ingredient options that are both widely accessible and sustainable. More information can be found at bensonhill.com or on Twitter at @bensonhillinc.

About ProTerra Foundation

The ProTerra Foundation is a not-for-profit organization located in the Netherlands that advances and promotes sustainability at all levels of the feed and food production system. Its mission is to be a global network of businesses supporting more sustainable agricultural practices in the agribusiness supply chains. The ProTerra Standard has been developed to promote social and environmental sustainability through the food and feed supply chains, to support stakeholders in their efforts to continuously improve their day-to-day business and to help organizations in engaging and implementing the concept of sustainable development. For details, please visit www.proterrafoundation.org.

Cautionary Note Regarding Forward-Looking Statements

Certain statements in this press release may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or the Company’s future financial or operating performance and may be identified by words such as “may,” “should,” “expect,” “intend,” “will,” “estimate,” “anticipate,” “believe,” “predict,” or similar words. These forward-looking statements are based upon assumptions made by the Company as of the date hereof and are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements include, among other things, statements regarding: the anticipated benefits of the Company’s ProTerra certification, ongoing sustainability and ESG initiatives, and farmer collaborations; the Company’s plans to promote sustainable agricultural practices and enhanced food supply chain transparency; anticipated advantages of the Company’s CleanCRUSH ingredients, including expectations regarding reduced carbon emissions and water usage; industry conditions and trends; the Company’s strategy and plans for growth; the expected future performance of and demand for the Company’s products; the Company’s ability to manage, develop and sustainably deliver its products to domestic and international markets; expectations about the markets in which the Company participates; and statements regarding the Company’s competitive positioning, resources, capabilities, and expectations for future performance. Factors that may cause actual results to differ materially from current expectations include, but are not limited to, risks associated with: the Company’s ability to realize the expected benefits of its ProTerra certification and to maintain its ProTerra certification; the Company’s ability to realize benefits associated with its ongoing sustainability and ESG initiatives and farmer collaborations; the success of the Company’s products and their ability to achieve expected results, including results related to sustainability benefits; the Company’s ability to grow and achieve growth profitably; the Company’s ability to maintain relationships with its customers, suppliers and strategic partners; changing industry conditions and consumer preferences; the Company’s ability to retain key personnel and generally execute on its business strategy; global and regional economic, agricultural, financial and commodities markets; political, social and health conditions, both domestically and internationally; the Company’s transition to becoming a public company; the effectiveness of the Company’s risk management strategies; and other risks and uncertainties set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in our filings with the Securities and Exchange Commission (“SEC”), which are available on the SEC’s website at www.sec.gov. We expressly disclaim any duty to update these forward-looking statements, except as otherwise required by law.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230118005254/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease1.5.2026 23:28:00 CEST | Press release

Jakafi XR is a once-daily, film-coated, extended-release formulation of Jakafi®(ruxolitinib)Once-daily Jakafi XR was shown to provide consistent, day-long exposure comparable to twice-daily JakafiJakafi XR will be available for pharmacy orders by May 8 Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meetin

Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 18:08:00 CEST | Press release

Drivers and team members of Formula 1® were reunited with their loved ones during a night that also celebrated the new partnership between Barilla and the Visa Cash App Racing Bulls Formula 1® Team. A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines wer

TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 12:07:00 CEST | Press release

Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the

Andersen Consulting styrker sine kompetencer inden for digital transformation med Weexa1.5.2026 10:07:00 CEST | Pressemeddelelse

Andersen Consulting indgår en samarbejdsaftale med Weexa, en global leverandør af løsninger inden for digital transformation, B2B-integration og digitalisering af forsyningskæden. Med hovedsæde i Frankrig leverer Weexa end-to-end-tjenester, der hjælper organisationer med at optimere, sikre og skalere deres digitale økosystemer. Virksomheden specialiserer sig i styring af B2B-datastrømme og digitalisering, hvilket muliggør problemfri kommunikation mellem applikationer både internt og på tværs af organisationer gennem teknologier som EDI, API'er og e-fakturering. Weexa tilbyder også SAP-integration og supply chain-løsninger til styring af lager og transport, sideløbende med strategisk rådgivning, projektlevering og vedligeholdelse af tredjepartsapplikationer. Weexa betjener organisationer inden for fødevaresektoren, detailhandel, engros, logistik, transport, bilindustrien, sundheds- og mediesektoren og hjælper globale virksomheder med at optimere deres ydeevne samt at overholde de nyeste

Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 01:17:00 CEST | Press release

Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye